<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cervical cancer screening recommendations from United States professional organizations*&lt;sup&gt;[1-6]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cervical cancer screening recommendations from United States professional organizations*<sup>[1-6]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Cervical cancer screening recommendations from United States professional organizations*<sup>[1-6]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="14%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1">Organization</td> <td class="subtitle1">Age to initiate (years)<sup>¶</sup></td> <td class="subtitle1">Age to discontinue (years)</td> <td class="subtitle1" colspan="2">Recommended screening test and frequency</td> <td class="subtitle1">Post-hysterectomy (with cervix removed) for benign disease</td> <td class="subtitle1">HPV vaccination</td> </tr> <tr> <td class="subtitle2_left" colspan="7">In our practice, we use the following guidelines, in order of preference:</td> </tr> <tr> <td class="indent1">USPSTF (2018)</td> <td>21</td> <td>65<sup>Δ</sup></td> <td> <p><strong>Age 21 to 29 years</strong></p> Pap test every 3 years</td> <td> <p><strong>Age ≥30 years</strong></p> One of these methods: <ul class="decimal_heading"> <li>Pap test every 3 years</li> <li>Primary HPV testing<sup>◊</sup> alone every 5 years</li> <li>Co-testing (Pap test and HPV testing) every 5 years</li> </ul> </td> <td>Not indicated<sup>§</sup></td> <td>Same recommendations as unvaccinated patients</td> </tr> <tr class="divider_bottom"> <td class="indent1">ACS (2020)</td> <td>25</td> <td>65<sup>¥</sup></td> <td colspan="2"> <p><strong>Age ≥25 years</strong></p> One of these methods: <ul class="decimal_heading"> <li>Primary HPV testing<sup>◊</sup> every 5 years (preferred)</li> <li>Co-testing (Pap test and HPV testing) every 5 years</li> <li>Pap test every 3 years</li> </ul> </td> <td>Not indicated<sup>‡</sup></td> <td>Same recommendations as unvaccinated patients</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Other expert group recommendations:</td> </tr> <tr> <td class="highlight_gray_text" colspan="3"> </td> <td><strong>Age 21 to 29 years</strong></td> <td><strong>Age ≥30 years</strong></td> <td class="highlight_gray_text" colspan="2"> </td> </tr> <tr> <td class="indent1">ACOG (2021)</td> <td>21</td> <td>65<sup>Δ</sup></td> <td>Pap test every 3 years</td> <td>One of these methods: <ul class="decimal_heading"> <li>Pap test every 3 years</li> <li>Primary HPV testing<sup>◊</sup> alone every 5 years</li> <li>Co-testing (Pap test and HPV testing) every 5 years</li> </ul> </td> <td>Not indicated<sup>§</sup></td> <td>Same recommendations as unvaccinated patients</td> </tr> <tr> <td class="indent1">ACP (2015)</td> <td>21</td> <td>65<sup>Δ</sup></td> <td>Pap test every 3 years</td> <td>One of these methods: <ul class="decimal_heading"> <li>Pap test every 3 years</li> <li>Alternative: Co-testing (Pap test and HPV testing) every 5 years</li> </ul> </td> <td>Not indicated<sup>§</sup></td> <td>N/A</td> </tr> <tr> <td class="indent1">ASCCP/SGO (2015 interim guidelines)</td> <td>21</td> <td>N/A</td> <td>Can consider primary HPV testing<sup>◊</sup> every 3 years for patients age ≥25</td> <td>Can consider primary HPV testing<sup>◊</sup> every 3 years</td> <td>N/A</td> <td>N/A</td> </tr> <tr> <td class="indent1">ACS/ASCCP/ASCP (2012)</td> <td>21<sup>¶</sup></td> <td>65<sup>†</sup></td> <td>Pap test every 3 years (preferred)</td> <td>One of these methods: <ul class="decimal_heading"> <li>Co-testing (Pap test and HPV testing) every 5 years (preferred)</li> <li>Pap test every 3 years</li> </ul> </td> <td>Not indicated**</td> <td>Same recommendations as unvaccinated patients</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>HPV: human papillomavirus; ACS: American Cancer Society; ASCCP: American Society for Colposcopy and Cervical Pathology; ASCP: American Society for Clinical Pathology; SGO: Society of Gynecologic Oncology; USPSTF: United States Preventive Services Task Force; ACOG: American College of Obstetricians and Gynecologists; ACP: American College of Physicians; DES: diethylstilbestrol; HIV: human immunodeficiency virus; CIN: cervical intraepithelial neoplasia; FDA: US Food and Drug Administration.</p>
<p>* These guidelines are intended for the general population and are not intended for patients with a history of cervical cancer, high-grade cervical precancers, DES in utero exposure, or who are immunocompromised (eg, HIV infection).</p>
<p>¶ Regardless of the age of initiation of sexual activity.</p>
<p>Δ For patients with no history of CIN 2 or higher with evidence of prior adequate screening (3 or more negative cytology test results in a row or 2 consecutive negative co-tests in the past 10 years, with the most recent within the past 5 years).</p>
<p>◊ Only certain HPV tests are approved by the FDA for primary HPV testing (ie, Cobas, BD Onclarity).</p>
<p>§ For patients who have had a benign hysterectomy with removal of the cervix who do not have a history of CIN 2 or higher.</p>
<p>¥ For patients with evidence of adequate negative prior screening (2 consecutive negative primary HPV tests or co-tests within the past 10 years, with the most recent test within the previous 5 years, or 3 consecutive negative Pap tests within the past 10 years, with the most recent test within the previous 3 years) and no history of CIN 2 or greater within the last 25 years. Screening should not be resumed for any reason, even if a woman has a new sexual partner.</p>
<p>‡ For patients who have had a benign hysterectomy with removal of the cervix who do not have a history of CIN 2 or 3 in the past 25 years, or a history of cervical cancer ever.</p>
<p>† For patients with evidence of adequate negative prior screening (consecutive negative cytology results or 2 consecutive negative co-tests within the previous 10 years, with the most recent test within the previous 5 years) and no history of CIN 2 or greater within the last 20 years. Screening should not be resumed for any reason, even if the patient has a new sexual partner.</p>
** For patients who have had a benign hysterectomy with removal of the cervix who do not have a history of CIN 2, CIN 3 in the past 20 years, or a history of cervical cancer ever.</div><div class="graphic_reference">References:
<ol>
<li>Curry SJ. Screening for cervical cancer: United States Preventive Services Task Force recommendation statement. JAMA 2018; 320:674.</li>
<li>Fontham ETH, Wolf AMD, Church TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin 2020.</li>
<li>Updated Cervical Cancer Screening Guidelines. The American College of Obstetricians and Gynecologists. Available at: <a href="https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines" target="_blank">www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines</a> (Accessed on February 16, 2023).</li>
<li>Sawaya GF, Kulasingam S, Denberg TD, et al. Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 2015; 162:851.</li>
<li>Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance. Gynecol Oncol 2015; 136:178.</li>
<li>Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012; 62:147.</li>
</ol></div><div id="graphicVersion">Graphic 82951 Version 23.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
